TWD 120.0
(0.42%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 465.92 Million TWD | 58140.13% |
2022 | 800 Thousand TWD | 0.0% |
2021 | - TWD | -100.0% |
2020 | 600 Thousand TWD | 119.05% |
2019 | -3.14 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -948 Thousand TWD | 0.0% |
2024 Q1 | - TWD | -100.0% |
2023 Q4 | 468.47 Million TWD | 58459.0% |
2023 FY | 469.27 Million TWD | 58559.0% |
2023 Q2 | - TWD | 0.0% |
2023 Q1 | - TWD | -100.0% |
2023 Q3 | 800 Thousand TWD | 0.0% |
2022 Q4 | 800 Thousand TWD | 0.0% |
2022 FY | 800 Thousand TWD | 0.0% |
2021 FY | - TWD | -100.0% |
2020 FY | 600 Thousand TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Allied Biotech Corporation | 246.43 Million TWD | -89.061% |
GeneFerm Biotechnology Co., Ltd. | 286.35 Million TWD | -62.71% |
Easywell Biomedicals, Inc. | 170.71 Million TWD | -172.918% |
TTY Biopharm Company Limited | 3.22 Billion TWD | 85.547% |
Synmosa Biopharma Corporation | 2.11 Billion TWD | 78.022% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 78.301% |
Center Laboratories, Inc. | 618.09 Million TWD | 24.62% |
Tien Liang BioTech Co., Ltd. | 286.14 Million TWD | -62.825% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 0.586% |
InnoPharmax Inc. | 17.45 Million TWD | -2568.964% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | -90.457% |
Excelsior Biopharma Inc. | 306.93 Million TWD | -51.8% |
DV Biomed Co., Ltd. | 764.27 Million TWD | 39.038% |
Foresee Pharmaceuticals Co., Ltd. | 113.97 Million TWD | -308.803% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 57.836% |
UniPharma Co., Ltd. | 51.01 Million TWD | -813.284% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | -17.38% |
Winston Medical Supply Co., Ltd. | 347.59 Million TWD | -34.04% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -78602.872% |
Bioray Biotech Co., Ltd | 77.65 Million TWD | -500.019% |
TSH Biopharm Corporation Limited | 399.89 Million TWD | -16.51% |